Literature DB >> 23021770

Analysis of gene expression profiles in alveolar epithelial type II-like cells differentiated from human alveolar epithelial progenitor cells.

Naoya Fujino1, Chiharu Ota, Takaya Suzuki, Satoshi Suzuki, Ahmed E Hegab, Mitsuhiro Yamada, Toru Takahashi, Mei He, Takashi Kondo, Hidemasa Kato, Mutsuo Yamaya, Hiroshi Kubo.   

Abstract

BACKGROUND: Damage to lung epithelial cells through chronic injury and abnormal repair and remodeling lead to lung destruction and fibrosis. We isolated lung progenitor cells that could potentially contribute to lung diseases. The progenitor cells can differentiate into alveolar type II (ATII)-like cells in vitro, and are increased in number and localized within the region of alveolar epithelial cell proliferation that is involved in the reparative response to injury. However, global gene expression patterns in the ATII-like cells derived from the progenitor cells and in mature ATII cells isolated from lung tissue have not yet been evaluated.
METHODS: We performed gene expression array and directly compared the gene expression patterns in ATII-like cells derived from the progenitor cells with those in mature ATII cells isolated from human lung tissues.
RESULTS: ATII-like cells and mature ATII cells expressed certain common genes, such as CEPBD and FOXP1, which determine the phenotypes of ATII cells. However, many genes were differentially expressed between the 2 cell types. As compared to mature ATII cells, ATII-like cells showed decreased expression of the genes associated with surfactant protein production and epithelial phenotypes. Pathway analysis indicated changes in several pathways, including those involved in epithelial-to-mesenchymal transition and receptor tyrosine kinase signaling, which could contribute to the observed differences in gene expression patterns.
CONCLUSIONS: In this study, we identified genes commonly or differentially expressed by ATII-like cells differentiated from progenitor cells and mature ATII cells isolated from human lung tissues.
Copyright © 2012 The Japanese Respiratory Society. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23021770     DOI: 10.1016/j.resinv.2012.07.002

Source DB:  PubMed          Journal:  Respir Investig        ISSN: 2212-5345


  6 in total

Review 1.  Stem cells, cell therapies, and bioengineering in lung biology and diseases. Comprehensive review of the recent literature 2010-2012.

Authors:  Daniel J Weiss
Journal:  Ann Am Thorac Soc       Date:  2013-10

2.  An official American Thoracic Society workshop report: stem cells and cell therapies in lung biology and diseases.

Authors:  Daniel J Weiss; Daniel Chambers; Adam Giangreco; Armand Keating; Darrell Kotton; Peter I Lelkes; Darcy E Wagner; Darwin J Prockop
Journal:  Ann Am Thorac Soc       Date:  2015-04

3.  Establishment of surfactant-associated protein A suicide gene system and analysis of its activity.

Authors:  Wan-Guang Zhang; Li He; Hua-Qing Su; Xue-Mei Shi; Bo Zhang; Si-Si Wu; Li Mei; Katirai Foad; Yong-Jian Xu; Zhen-Xiang Zhang; Jian-Ping Zhao; Wei-Ning Xiong; Guo-Hua Zhen; Hui-Lan Zhang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2014-06-18

Review 4.  Stem/progenitor cells in endogenous repairing responses: new toolbox for the treatment of acute lung injury.

Authors:  Ce Yang; Jianxin Jiang; Xuetao Yang; Haiyan Wang; Juan Du
Journal:  J Transl Med       Date:  2016-02-11       Impact factor: 5.531

Review 5.  [Advances in Classification and Research Methods of Lung Epithelial Stem 
and Progenitor Cells].

Authors:  Minhua Deng; Jinhua Li; Ye Gan; Ping Chen
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2017-02-20

Review 6.  Neglected, yet significant role of FOXP1 in T-cell quiescence, differentiation and exhaustion.

Authors:  Yaroslav Kaminskiy; Varvara Kuznetsova; Anna Kudriaeva; Ekaterina Zmievskaya; Emil Bulatov
Journal:  Front Immunol       Date:  2022-10-04       Impact factor: 8.786

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.